Vermillion, Inc. Deals and Alliances Profile Introduction Vermillion, Inc. (VRML) is engaged in the discovery, development, and commercialization of diagnostic products. It develops clinical protein biomarker diagnostic products and services in the fields of cardiology, oncology and hematology. Vermillion is developing three ovarian cancer blood tests that has the potential to diagnose early-stage disease, predict prognosis and recurrence, distinguish between benign and malignant tumors. The company provides diagnostic products for the treatment of peripheral artery disease, ovarian tumor triage test, and thrombotic thrombocytopenic purpura (TTP) test. Global Market Directs Vermillion, Inc. Deals and Alliances Profile is the essential source for company data and information. The profile examines the companys key business structure and operations, history and products, as well as highlights the companys major recent financial deals. Scope Provides all the crucial company information required for business and competitor intelligence needs Gives information on the companys major recent financial deals. Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.Reasons to Purchase Obtain up to date company information. Support sales activities by understanding your customers businesses. Qualify prospective partners and suppliers. Understand and respond to your competitors business structure, strategy and prospects.
|
